Solventum Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	8,262	8,325	8,254	8,197	8,130	8,171
Revenue Growth (YoY)	-0.55%	0.86%	0.69%	0.82%	-0.50%	12.22%
Cost of Revenue	3,829	3,874	3,661	3,504	3,435	3,248
Gross Profit	4,434	4,451	4,593	4,693	4,695	4,923
Selling, General & Admin	3,138	3,080	2,782	2,299	2,235	2,278
Research & Development	736	739	775	758	767	766
Other Operating Expenses	-	-1,549	-	-56	-	-
Total Operating Expenses	3,874	2,270	3,557	3,001	3,002	3,044
Operating Income	2,109	2,181	1,036	1,692	1,693	1,879
Interest Expense	-305	-347	-367	-	-	-
Other Non-Operating Income (Expense)	-32	-121	-64	-25	-1	3
Total Non-Operating Income (Expense)	-337	-468	-431	-25	-1	3
Pretax Income	1,691	1,713	605	1,667	1,692	1,882
Provision for Income Taxes	259	157	127	321	349	422
Net Income	1,432	1,556	479	1,346	1,343	1,460
Net Income to Common	1,432	1,556	479	1,346	1,343	1,460
Net Income Growth	277.84%	224.84%	-64.41%	0.22%	-8.01%	28.29%
Shares Outstanding (Basic)	174	174	173	173	173	-
Shares Outstanding (Diluted)	175	175	174	173	173	-
Shares Change (YoY)	0.73%	0.92%	0.58%	-	-	-
EPS (Basic)	8.21	8.94	2.77	7.79	7.78	-
EPS (Diluted)	8.16	8.88	2.76	7.79	7.78	-
EPS Growth	277.78%	221.74%	-64.57%	0.13%	-	-
EBIT	2,109	2,181	1,036	1,692	1,693	1,879

SEC Filings: 10-K · 10-Q